CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+4.05%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$8B
AUM Growth
+$8B
(+2.4%)
Cap. Flow
-$814M
Cap. Flow
% of AUM
-10.17%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
870
New
73
Increased
308
Reduced
303
Closed
63
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$50.9M |
| 2 |
Procter & Gamble
PG
|
$26.1M |
| 3 |
Keysight
KEYS
|
$24.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$22.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
$20.5M |
Top Sells
| 1 |
ManpowerGroup
MAN
|
$744M |
| 2 |
CELG
Celgene Corp
CELG
|
$45.1M |
| 3 |
Exxon Mobil
XOM
|
$36.1M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$28.3M |
| 5 |
Walt Disney
DIS
|
$26.8M |
Sector Composition
| 1 | Healthcare | 33.22% |
| 2 | Technology | 16.94% |
| 3 | Financials | 10.4% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Texas Instruments
TXN
$178B
| $31M | 0.39% |
250,384
+41,072
| +20% | +$5.09M |
|
|
ARQL
52
DELISTED
Arqule Inc
ARQL
| $30.2M | 0.38% |
2,755,237
+1,353,056
| +96% | +$14.8M |
|
53
Starbucks
SBUX
$99.2B
| $30M | 0.37% |
359,295
+124,833
| +53% | +$10.4M |
|
54
Sarepta Therapeutics
SRPT
$1.98B
| $29.1M | 0.36% |
192,600
| – | – |
|
|
ONC
55
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $28.8M | 0.36% |
233,752
+50,520
| +28% | +$6.23M |
|
56
PTC Therapeutics
PTCT
$4.41B
| $28.7M | 0.36% |
640,523
+178,000
| +38% | +$7.97M |
|
57
IBM
IBM
$227B
| $28.3M | 0.35% |
193,738
+6,192
| +3% | +$903K |
|
58
Alnylam Pharmaceuticals
ALNY
$58.6B
| $27.6M | 0.34% |
381,724
+97,023
| +34% | +$7.01M |
|
59
Palo Alto Networks
PANW
$128B
| $27.5M | 0.34% |
135,549
+59,703
| +79% | +$12.1M |
|
60
Thermo Fisher Scientific
TMO
$183B
| $27.3M | 0.34% |
93,500
+20,429
| +28% | +$5.97M |
|
61
Danaher
DHR
$143B
| $26.5M | 0.33% |
186,098
+10,054
| +6% | +$1.43M |
|
62
Analog Devices
ADI
$120B
| $26.4M | 0.33% |
234,637
+59,743
| +34% | +$6.71M |
|
63
Intel
INTC
$105B
| $26M | 0.32% |
496,113
-68,778
| -12% | -$3.61M |
|
64
Prudential Financial
PRU
$37.8B
| $25.9M | 0.32% |
238,677
-41,178
| -15% | -$4.47M |
|
|
65
Exxon Mobil
XOM
$477B
| $25.9M | 0.32% |
338,825
-473,240
| -58% | -$36.1M |
|
|
66
Keysight
KEYS
$28.4B
| $25.5M | 0.32% |
284,789
+273,244
| +2,367% | +$24.4M |
|
67
Sherwin-Williams
SHW
$90.5B
| $25.1M | 0.31% |
54,929
-4,240
| -7% | -$1.93M |
|
68
Union Pacific
UNP
$132B
| $25M | 0.31% |
148,269
-1,117
| -0.7% | -$188K |
|
69
NextEra Energy, Inc.
NEE
$148B
| $24.7M | 0.31% |
112,270
+55,545
| +98% | +$12.2M |
|
70
Schlumberger
SLB
$52.2B
| $24.6M | 0.31% |
621,099
+116,740
| +23% | +$4.62M |
|
71
Caterpillar
CAT
$194B
| $24.1M | 0.3% |
177,741
+96,494
| +119% | +$13.1M |
|
72
Newmont
NEM
$82.8B
| $23.9M | 0.3% |
623,435
+249,349
| +67% | +$9.55M |
|
73
3M
MMM
$81B
| $23.6M | 0.29% |
136,631
+14,462
| +12% | +$2.5M |
|
|
RETA
74
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $23.4M | 0.29% |
249,200
| – | – |
|
75
Neurocrine Biosciences
NBIX
$13.5B
| $22.5M | 0.28% |
267,669
-25,000
| -9% | -$2.1M |
|